can i still get tirzepatide compounded (GLP-1/GIP) Compounded Tirzepatide — Compounded dual
Description
(28) The crude incidence rates of LLA were 6.1 per 10,000 person-years for GLP-1 receptor agonists, 1.5 for SGLT-2 inhibitors, 4.6 for DPP-4 inhibitors, and 1.9 for older agents
It does seem like its on the border, though. When manufacturers, packers, distributors or their representatives promote prescription drugs to consumers and health care providers, the FDA says, it requires these communications to be truthful, balanced and not misleading
Always verify your eligibility, medical history and the nature of the continuing treatment
If it has been longer than 5 days, do not take the missed dose
